On June 4, 2007, the FDA announced the formation of a new committee to advise on how to improve communication of the risks and benefits of FDA approved products to the public. The FDA's Deputy Commissioner for Policy, Randall Luter, stated that "the Risk Communication Advisory Committee will bring together a broad range of experts and views to help improve FDA's communication of the science-based information about product risks and benefits that the public needs to make informed decisions.” The committee will consist of up to 15 members, not affiliated with the FDA, including both experts and members of the public. Experts will be drawn from the fields of risk communication, social marketing, health literacy, journalism, and bioethics, amongst others. The public members of the committee will include those who can provide the perspective of users of FDA approved products including consumers, patients, caregivers and health professionals.

For more information, please see: